Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02262000 · ClinicalTrials.gov registry record · NA
Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer
A NA study, sponsored by West Virginia University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02262000: Clinical Trial NA study, sponsored by West Virginia University.
NCT02262000 is a NA study that was terminated before completion, run by West Virginia University. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02262000, a NA study, was terminated before completion, sponsored by West Virginia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study will help researchers learn about the best dose of radiation to be used when treating large early stage non-small cell lung cancer (NSCLC) with a treatment called stereotactic ablative radiotherapy (SABR). Current treatments with SABR for early stage NSCLC show positive response. But, for large early stage NSCLC it may be better to give different SABR doses than what is used in routine early stage NSCLC treatment. It is not understood which dose is best for treating large early stage NSCLC. Therefore, this study can help researchers learn if giving a higher dose using SABR over a period of 5-10 treatment days can increase the chance of cure for large early stage NSCLC.
Interventions
- RADIATION Image Guided Stereotactic Ablative Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-07-10 |
| Phase | NA |
Why NCT02262000 stopped before completion
NCT02262000 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Image Guided Stereotactic Ablative Radiotherapy is the first listed.
NCT02262000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02262000 about?
NCT02262000 is a clinical study titled "Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer". This study will help researchers learn about the best dose of radiation to be used when treating large early stage non-small cell lung cancer (NSCLC) with a treatment called stereotactic ablative radiotherapy (SABR). Current treatments with SABR for early stage NSCLC show positive response. But, for...
What is the current status of trial NCT02262000?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2013-09. Estimated completion is 2017-07-10.
What interventions are being tested in trial NCT02262000?
The interventions under investigation include: Image Guided Stereotactic Ablative Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT02262000?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02262000's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia